Published 21 hours ago • loading... • Updated 21 hours ago

AMGEN TO PRESENT AT THE 8TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE

On Nov. 24, 2025, Amgen said it will present at the Evercore ISI HealthCONx Conference at 10:00 a.m. ET on December 3, 2025.
The presentation is meant to share developments in Amgen's business and provide updates on pipeline, strategy and performance, advancing medicines for patients with cancer, heart disease, osteoporosis, inflammatory and rare diseases.
Peter Griffith, executive vice president and chief financial officer, Amgen, will present alongside Jay Bradner, executive vice president of Research and Development, Amgen.
A webcast will be broadcast over the internet and available to news media, investors and the general public, with links on Amgen's Investor Relations Events Calendar and website.
With more than 40 years of history, Amgen is part of the Dow Jones Industrial Average and the Nasdaq-100, reflecting its market stature and recent industry recognitions.

Insights by Ground AI

20 Articles

iBio to Participate in the 8th Annual Evercore Healthcare Conference

SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the 8th...

21 hours ago·Manila, Philippines

Read Full Article

lasvegasoptic.com

Center

AMGEN TO PRESENT AT THE 8TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE

THOUSAND OAKS, Calif., Nov. 24, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 8th annual Evercore ISI HealthCONx Conference at 10:00 a.m. ET on December 3, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and…

22 hours ago

Read Full Article